/주식/UNCY
UNCY

UNCY

Unicycive Therapeutics Inc. Common Stock

$0.638+0.000 (0.000%)

실시간 가격

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$0.638

고가

$0.638

저가

$0.638

거래량

4.18M

기업 기본 정보

거래 통계

관련 뉴스

GlobeNewswire

Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

- The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor - FDA to provide final decision by PDUFA action date of June 28, 2025 LOS ALTOS, Calif., June 10,

더 보기
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Analyst Upgrades

HC Wainwright & Co. Assumes Unicycive Therapeutics at Buy, Announces Price Target of $9

HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Unicycive Therapeutics with a Buy rating and announces Price Target of $9.

더 보기
HC Wainwright & Co. Assumes Unicycive Therapeutics at Buy, Announces Price Target of $9
GlobeNewswire

Unicycive Therapeutics to Present at Upcoming Investor Conferences

LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh

더 보기
Unicycive Therapeutics to Present at Upcoming Investor Conferences